Congressman Chip Roy (R-TX) is demanding in a letter to know why the Biden administration and Human Health and Services are rationing monoclonal antibodies in Texas and across the nation and why they aren’t stepping up manufacturing of the life-saving treatment.
He sent the letter to Department of Health and Human Services Secretary Xavier Becerra on Thursday. In it, Roy also demanded to know why there was a shortage of it in the first place.
He claims to have three questions that he says “should not be hard” for HHS to answer.
“My recurring inquiries as discussed in multiple letters and reiterated over a bicameral congressional briefing led by your Department on September 17, 2021, have been focused on a few main questions: 1) Is there, or has there ever been a shortage of any monoclonal antibody treatments in the U.S.? If so, which treatments? 2) Is there an expected shortage of any monoclonal antibody treatment in the U.S; and If so, which treatments? 3) What is the U.S.’s manufacturing capacity for monoclonal antibody treatments?” Roy inquired.
Roy noted that COVID cases are increasing across the country and that Omicron is now the dominant variant. He went on to assert that only one monoclonal antibody, Sotrovimab, “appears to be working” for those who contract the strain.
The congressman also charged that “in Texas, including in Austin, El Paso, Fort Worth, San Antonio, and the Houston area, sites have completely run out of Sotrovimab and have no choice but to wait without recourse because your Department has taken full control of the supply chain.”
A doctor in Maryland reports that he had to cancel monoclonal antibody infusions for about 250 people over the last week after the federal government stopped distributing treatments because they aren’t effective against the Omicron variant, according to Fox News. They do not have Sotrovimab available to them there, evidently.
The CDC originally said Omicron was responsible for 73.2% of all new cases. But they backtracked on that estimate, revising it down to just 22.5%, a more than 50-point drop.
“I am as angry as I possibly can be about this,” Dr. Ron Elfenbein, the medical director and CEO of FirstCall Medical Center in Gambrills, Maryland, told Fox News Digital Wednesday.
“The fact that these people are so adamant that they’re right when they’re using faulty data and they’re using faulty logic and frankly statistical modeling that has never been correct, ever, throughout this entire pandemic, to look at this, is just beyond the pale…. People are definitely going to die because of this or need hospitalization because [health officials] misread the statistics,” he proclaimed.
As Roy’s letter points out, the Sotrovimab website warns on the home page that “GSK has entered into a contract with the U.S. government to purchase Sotrovimab. Sotrovimab is not available for commercial purchase at this time. More details of government-directed distribution will be provided in the coming weeks.”
Unbelievably, the MacArthur Medical Center in Irving, Texas is declaring that “Latin X or Black” patients will automatically qualify for monoclonal antibody treatments. But those who are white must qualify by being obese, having heart disease, or being 65 or older.
The CDC originally said Omicron was responsible for 73.2% of all new cases. But they backtracked on that estimate, revising it down to just 22.5%, a more than 50-point drop.
“I am as angry as I possibly can be about this,” Dr. Ron Elfenbein, the medical director and CEO of FirstCall Medical Center in Gambrills, Maryland, told Fox News Digital Wednesday.
“The fact that these people are so adamant that they’re right when they’re using faulty data and they’re using faulty logic and frankly statistical modeling that has never been correct, ever, throughout this entire pandemic, to look at this, is just beyond the pale…. People are definitely going to die because of this or need hospitalization because [health officials] misread the statistics,” he proclaimed.
As Roy’s letter points out, the Sotrovimab website warns on the home page that “GSK has entered into a contract with the U.S. government to purchase Sotrovimab. Sotrovimab is not available for commercial purchase at this time. More details of government-directed distribution will be provided in the coming weeks.”
Unbelievably, the MacArthur Medical Center in Irving, Texas is declaring that “Latin X or Black” patients will automatically qualify for monoclonal antibody treatments. But those who are white must qualify by being obese, having heart disease, or being 65 or older.
Read More HERE
1 comment:
Do YOU mean to Tell ME that Maahh GUVahhMint would InTENchionally limit access to and CRE ATE ,actually MANahFactcher a shortage? Suhh!AHMM OFFended!
Post a Comment